Congress recently began hearings on proposals to combat opioid abuse. Our policy analyst weighs in.
Devon Herrick, PhD
About half of states have transitioned at least some Medicaid beneficiaries away from fee-for-service (FFS) drug programs into drug plans integrated with managed care. Our policy analyst shares why he believes more should do so.
Across the country more states are taking steps to limit patients’ exposure to surprise out-of-network bills.
Our policy analyst explains why he believes single payer Medicare-for-all is a pipe dream.
Our policy analyst explains the concept of invisible high-risk pools, and explains how they might affect health reform.
Our policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.
None of Trump’s plans, such as repealing parts of Obamacare or expanding HSAs, will rein in the rising cost of healthcare.